Universal maternal drug testing in a high-prevalence region of prescription opiate abuse

Journal of Pediatrics

Volumn 166, Issue 3, 2015, Pages 582-586

  Wexelblatt, Scott L ^a,b,c   Ward, Laura P ^a,b,c   Torok, Kimberly ^c   Tisdale, Elizabeth ^c   Meinzen Derr, Jareen K ^a   Greenberg, James M ^a,b,c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c Mercy Hospital Anderson   (United States)

Author keywords

NAS Neonatal abstinence syndrome; SCN; Siemens 1650 enzyme immunoassay; Special care nursery; UDS9

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; OPIATE; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ARTICLE; COHORT ANALYSIS; COMMUNITY HOSPITAL; DRUG ABUSE; DRUG SCREENING; DRUG USE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MATERNAL CARE; MATERNAL DRUG TESTING; MEDICAL RECORD REVIEW; NURSERY; PERSONAL EXPERIENCE; PRACTICE GUIDELINE; PRENATAL CARE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; SOLUTIO PLACENTAE; URINALYSIS; WITHDRAWAL SYNDROME; ADULT; COMPLICATION; FOLLOW UP; MALE; NEONATAL ABSTINENCE SYNDROME; NEWBORN; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATION; RECEIVER OPERATING CHARACTERISTIC; UNITED STATES;

ADULT; ANALGESICS, OPIOID; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MALE; NEONATAL ABSTINENCE SYNDROME; OHIO; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PRESCRIPTION DRUGS; PREVALENCE; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84924561739     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.10.004     Document Type: Article

References (24)

1. S.W. Patrick, R.E. Schumacher, B.D. Benneyworth, E.E. Krans, J.M. McAllister, and M.M. Davis Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009 JAMA 307 2012 1934 1940
2. Massatti R, Falb M, Yors A, Potts L, Beeghly C, Starr S. Neonatal abstinence syndrome and drug use among pregnant women in Ohio, 2004-2011. Columbus, OH: Ohio Department of Mental Health and Addiction Services 2013;28.
3. N.S. Seligman, C.V. Almario, E.J. Hayes, K.C. Dysart, V. Berghella, and J.K. Baxter Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome J Pediatr 157 2010 428 433 433.e1
4. A. Kellogg, C.H. Rose, R.H. Harms, and W.J. Watson Current trends in narcotic use in pregnancy and neonatal outcomes Am J Obstet Gynecol 204 2011 259.e1 259.e4
5. C. Zelson, E. Rubio, and E. Wasserman Neonatal narcotic addiction: 10-year observation Pediatrics 48 1971 178 189
6. M. O'Donnell, N. Nassar, H. Leonard, R. Hagan, R. Mathews, and Y. Patterson Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement Pediatrics 123 2009 e614 e621
7. D.A. Osborn, H.E. Jeffery, and M.J. Cole Opiate treatment for opiate withdrawal in newborn infants Cochrane Database Syst Rev 2010 CD002059
8. P.K. Jaudes, E. Ekwo, and J. Van Voorhis Association of drug abuse and child abuse Child Abuse Negl 19 1995 1065 1075
9. S.R. Kandall, S. Albin, J. Lowinson, B. Berle, A.I. Eidelman, and L.M. Gartner Differential effects of maternal heroin and methadone use on birthweight Pediatrics 58 1976 681 685
10. ACOG Committee on Health Care for Underserved Women, and American Society of Addiction ACOG Committee opinion no. 524: opioid abuse, dependence, and addiction in pregnancy Obstet Gynecol 119 2012 1070 1076
11. D.J. Goodman, and K.B. Wolff Screening for substance abuse in women's health: a public health imperative J Midwifery Womens Health 58 2013 278 287
12. B.M. Lester, M. ElSohly, L.L. Wright, V.L. Smeriglio, J. Verter, and C.R. Bauer The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report Pediatrics 107 2001 309 317
13. E.S. Hall, S.L. Wexelblatt, M. Crowley, J.L. Grow, L.R. Jasin, and M.A. Klebanoff A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome Pediatrics 134 2014 e527 e534
14. M.L. Hudak, R.C. Tan, Committee on Drugs, Committee on Fetus and Newborn, and American Academy of Pediatrics Neonatal drug withdrawal Pediatrics 129 2012 e540 e560
15. L.P. Finnegan, J.F. Connaughton Jr., R.E. Kron, and J.P. Emich Neonatal abstinence syndrome: assessment and management Addict Dis 2 1975 141 158
16. J.M. Wilson, and Y.G. Jungner Principles and practice of mass screening for disease Bol Oficina Sanit Panam 65 1968 281 393 (in Spanish)
17. A. Andermann, I. Blancquaert, S. Beauchamp, and V. Dery Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years Bull World Health Organ 86 2008 317 319
18. P.I. Carter Applying your corporate compliance skills to the HIPAA security standard J Healthc Inf Manag 14 2000 13 27
19. N.C. Goler, M.A. Armstrong, V.M. Osejo, Y.Y. Hung, M. Haimowitz, and A.B. Caughey Early start: a cost-beneficial perinatal substance abuse program Obstet Gynecol 119 2012 102 110
20. H.E. Jones, K. Kaltenbach, S.H. Heil, S.M. Stine, M.G. Coyle, and A.M. Arria Neonatal abstinence syndrome after methadone or buprenorphine exposure N Engl J Med 363 2010 2320 2331
21. D.L. Frederick Toxicology testing in alternative specimen matrices Clin Lab Med 32 2012 467 492
22. S.J. Ondersma, L.H. Malcoe, and S.M. Simpson Child protective services' response to prenatal drug exposure: results from a nationwide survey Child Abuse Negl 25 2001 657 668
23. E.G. Livingston Universal screening for HIV in pregnant women? Medscape Womens Health 2 1997 1
24. R.A. Herzlinger, S.R. Kandall, and H.G. Vaughan Jr. Neonatal seizures associated with narcotic withdrawal J Pediatr 91 1977 638 641